-
Actavis, Warner Chilcott meet last regulatory requirements for merger
DUBLIN — Ireland's High Court has approved Actavis' acquisition of Warner Chilcott, the drug makers said.
The companies said the approval of Irish authorities meant that they had obtained all regulatory approvals required to complete the transaction, and that it now remained subject to satisfaction of other customary closing conditions and would occur as soon as practicable.
Actavis and Warner Chilcott announced the $8.5 billion merger deal in May. The companies' shareholders voted to approve it on Sept. 10.
-
HDMA re-elects chair and vice chair, names two new board members
ARLINGTON, Va. — The Healthcare Distribution Management Association on Tuesday announced the re-election of David Neu, president of AmerisourceBergen Drug Corp. as chairman of its board of directors. Ted Scherr, president and CEO of Dakota Drug, also was re-elected as vice chairman.
Additionally, HDMA welcomed two members to the Board. Mark Walchirk, president of McKesson U.S. Pharmaceutical, was elected to replace Paul Julian, EVP and group president of McKesson Corporation, on the board and executive committee.